Dual-Regulated Mechanism of EZH2 and KDM6A on SALL4 Modulates Tumor Progression via Wnt/β-Catenin Pathway in Gastric Cancer

BackgroundSALL4 has been demonstrated in many cancers and participated in tumorigenesis and tumor progression, however, its expression and function still remain ambiguous in GC, especially its upstream mechanistic modulators.Purpose We explored whether the dual mediation of EZH2 and KDM6A could be involved in upstream regulation of SALL4, which promotes GC cell progression via the Wnt/beta-catenin pathway.Method Analysis of discrepant gene expression in GC and normal gastric tissues from The Cancer Genome Atlas (TCGA) dataset. GC cell lines were transfected by siEZH2 and siKDM6A, the transduction molecules of KDM6A/EZH2-SALL4-beta-catenin signaling were quantified in the GC cells.Results Here, we showed that only SALL4 levels of SALL family members were upregulated in nonpaired and paired GC tissues than those in corresponding normal tissues and were associated with its histological types, pathological stages, TNM stages including T stage (local invasion), N stage (lymph node metastasis), M stage (distant metastasis), and overall survival from the TCGA dataset. SALL4 level was elevated in GC cells compared to normal gastric epithelial cell line (GES-1) and was correlated to cancer cell progression and invasion through the Wnt/beta-catenin pathway in GC, which levels would be separately upregulated or downregulated by KDM6A or EZH2.Conclusion We first proposed and demonstrated that SALL4 promoted GC cell progression via the Wnt/beta-catenin pathway, which was mediated by the dual regulation of EZH2 and KDM6A on SALL4. This mechanistic pathway in gastric cancer represents a novel targetable pathway.

Automated summary

This study investigates the dual regulation of EZH2 and KDM6A in the upstream modulation of SALL4, promoting GC cell progression via the Wnt/beta-catenin pathway. The results show that SALL4 is upregulated in GC cells and regulates the progression and invasion of GC cells through the Wnt/beta-catenin pathway, which can be separately upregulated or downregulated by KDM6A or EZH2.